In 2023, the market for antibacterial medicine in Italy stood at 1.08 Billion US Dollars PPP. Forecasted sales for 2024 are estimated to be 1.06 Billion US Dollars PPP, indicating a slight year-on-year decline of approximately 1.85%. The trend continues with a year-on-year decline of about 1.89% in 2025, 1.92% in 2026, and 1.96% in 2027. By 2028, sales are forecasted to decrease to 0.9823 Billion US Dollars PPP, representing an average annual decline (CAGR) of about 1.85% over this five-year period.
Future trends to watch for include the development of antibiotic resistance which might drive innovation and higher sales of newer, more effective antibacterial medicines. Economic conditions, healthcare policies, and changes in patient demographics could also impact these projections.
